New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer, according to scientists at the Karolinska Institute and Uppsala University, along with colleagues in the U.K. and U.S. Their study […]
The post Tailored Cancer Drugs from New Cell Receptor Insights appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Tailored Cancer Drugs from New Cell Receptor Insights